
CAS 2414909-94-5
:Fórmula:C19H16N6O
InChI:InChI=1S/C19H16N6O/c20-18(26)15-5-3-14(4-6-15)16-12-23-25-9-7-17(24-19(16)25)22-11-13-2-1-8-21-10-13/h1-10,12H,11H2,(H2,20,26)(H,22,24)
Chave InChI:LMGXQBQAUALFTB-UHFFFAOYSA-N
SMILES:C1=CC(=CN=C1)CNC2=NC3=C(C=NN3C=C2)C4=CC=C(C=C4)C(=O)N
Filtrar por
Percentagem de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 7 produtos.
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
4-(5-((Pyridin-3-Ylmethyl)Amino)Pyrazolo[1,5-A]Pyrimidin-3-Yl)Benzamide
CAS:4-(5-((Pyridin-3-Ylmethyl)Amino)Pyrazolo[1,5-A]Pyrimidin-3-Yl)BenzamideFórmula:C19H16N6OPureza:>98%Peso molecular:344.374-[5-(3-Pyridylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide
CAS:Fórmula:C19H16N6OPureza:98%Cor e Forma:SolidPeso molecular:344.3699RET V804M-IN-1
CAS:4-(5-((Pyridin-3-ylmethyl)amino)pyrazolo[1,5-a]pyrimidin-3-yl)benzamideFórmula:C19H16N6OPureza:98+%Peso molecular:344.37RET V804M-IN-1
CAS:RET V804M-IN-1 (RETV804M kinase inhibitor) is a wt-RET -selective RETV804M kinase inhibitors(IC50 = 20 nM).Fórmula:C19H16N6OPureza:97.94% - 99.62%Cor e Forma:White SolidPeso molecular:344.3699RET V804M-IN-1
CAS:Selective inhibitor of the mutated RET variant RETV804M, which is the anticipated drug-resistant RET mutant that can occur in tumours treated with kinase inhibitors. The compound has a biochemical IC50 of 0.02 µM and selectivity for purified RETV804M over purified RET and KDR of 3.7 and 110, respectively. The efficacy of the compound was shown also in cell cultures with IC50 of 4.4 µM, and cell assay selectivity for RETV804M over RET and KDR of 0.89 and 2.3, respectively.
Fórmula:C19H16N6OPureza:Min. 97 Area-%Cor e Forma:White PowderPeso molecular:344.37 g/mol4-(5-((PYRIDIN-3-YLMETHYL)AMINO)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL)BENZAMIDE
CAS:Pureza:98+%Peso molecular:344.3779907





